Disclosed is 4-[2,3-difluoro-6-(2-fluoro-4-methylphenylsulfanyl)-phenyl]-piperidine as depicted in formula (I). Also disclosed is a pharmaceutical composition comprising a compound of formula (I) and the use of a compound of formula (I) for the manufacture of a medicament for treating or preventing a disease selected from major depressive disorder dysthymic disorder mood disorder due to a general medical condition atypical depression seasonal affective disorder melancholia treatment resistant depression partial responders depression associated with bipolar disorder, pain, Alzheimers disease, psychosis, Parkinsons disease, Lewy body disease, Huntingtons disease, multiple sclerosis or anxiety general anxiety disorder social anxiety disorder panic attacks phobia social phobia, obsessive compulsive disorder post-traumatic stress disorder acute stress ADHD and pain.
